nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—Abdominal pain upper—Sorafenib—thyroid cancer	0.0408	0.0408	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Vandetanib—thyroid cancer	0.0399	0.0399	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Sorafenib—thyroid cancer	0.037	0.037	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Vandetanib—thyroid cancer	0.0319	0.0319	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Vandetanib—thyroid cancer	0.0287	0.0287	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Vandetanib—thyroid cancer	0.0283	0.0283	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.0281	0.0281	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Vandetanib—thyroid cancer	0.0281	0.0281	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Sorafenib—thyroid cancer	0.0269	0.0269	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0266	0.0266	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Vandetanib—thyroid cancer	0.0257	0.0257	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Vandetanib—thyroid cancer	0.0234	0.0234	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Vandetanib—thyroid cancer	0.0223	0.0223	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Sorafenib—thyroid cancer	0.0215	0.0215	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Vandetanib—thyroid cancer	0.0215	0.0215	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Vandetanib—thyroid cancer	0.0207	0.0207	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Vandetanib—thyroid cancer	0.0205	0.0205	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Vandetanib—thyroid cancer	0.0205	0.0205	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Vandetanib—thyroid cancer	0.0204	0.0204	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Vandetanib—thyroid cancer	0.0193	0.0193	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Sorafenib—thyroid cancer	0.0193	0.0193	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Sorafenib—thyroid cancer	0.0191	0.0191	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.019	0.019	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Sorafenib—thyroid cancer	0.0189	0.0189	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Sorafenib—thyroid cancer	0.018	0.018	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Sorafenib—thyroid cancer	0.0174	0.0174	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Sorafenib—thyroid cancer	0.0158	0.0158	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Epirubicin—thyroid cancer	0.0151	0.0151	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Sorafenib—thyroid cancer	0.015	0.015	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Sorafenib—thyroid cancer	0.0145	0.0145	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Sorafenib—thyroid cancer	0.014	0.014	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Doxorubicin—thyroid cancer	0.014	0.014	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Sorafenib—thyroid cancer	0.0138	0.0138	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Sorafenib—thyroid cancer	0.0138	0.0138	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Sorafenib—thyroid cancer	0.0138	0.0138	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Sorafenib—thyroid cancer	0.013	0.013	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Epirubicin—thyroid cancer	0.00994	0.00994	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Epirubicin—thyroid cancer	0.0098	0.0098	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Doxorubicin—thyroid cancer	0.0092	0.0092	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Doxorubicin—thyroid cancer	0.00906	0.00906	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Epirubicin—thyroid cancer	0.00796	0.00796	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Doxorubicin—thyroid cancer	0.00736	0.00736	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Epirubicin—thyroid cancer	0.00714	0.00714	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Epirubicin—thyroid cancer	0.00705	0.00705	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00701	0.00701	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Epirubicin—thyroid cancer	0.007	0.007	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00664	0.00664	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Doxorubicin—thyroid cancer	0.00661	0.00661	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Doxorubicin—thyroid cancer	0.00653	0.00653	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00648	0.00648	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Doxorubicin—thyroid cancer	0.00647	0.00647	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Epirubicin—thyroid cancer	0.00641	0.00641	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00614	0.00614	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Doxorubicin—thyroid cancer	0.00594	0.00594	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Epirubicin—thyroid cancer	0.00582	0.00582	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Epirubicin—thyroid cancer	0.00555	0.00555	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Doxorubicin—thyroid cancer	0.00539	0.00539	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Epirubicin—thyroid cancer	0.00537	0.00537	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Epirubicin—thyroid cancer	0.00516	0.00516	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Doxorubicin—thyroid cancer	0.00514	0.00514	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Epirubicin—thyroid cancer	0.00512	0.00512	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Epirubicin—thyroid cancer	0.00511	0.00511	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Epirubicin—thyroid cancer	0.00508	0.00508	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Doxorubicin—thyroid cancer	0.00496	0.00496	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Epirubicin—thyroid cancer	0.00482	0.00482	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Doxorubicin—thyroid cancer	0.00477	0.00477	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Doxorubicin—thyroid cancer	0.00473	0.00473	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Doxorubicin—thyroid cancer	0.00473	0.00473	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Doxorubicin—thyroid cancer	0.0047	0.0047	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Doxorubicin—thyroid cancer	0.00446	0.00446	CcSEcCtD
